Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar

Day-3 Positive of Parasitaemia Clinical Trial

Official title: Molecular Assessment of Artemisinin Resistance Markers, K13 Kelch Propeller and Multi-drug Resistant Gene Polymorphism in Eastern and Western Border Areas of Myanmar

Status Completed

Clinical Trial Summary

• Artemisinin resistance have been documented in Myanmar and Myanmar artemisinin resistance containment measures have been launched since 2009-2010.

• It is important to monitor the spread and magnitude of artemisinin resistant malaria in Myanmar.

• So, day-3 surveillance study have been conducted.

• Recently artemisinin resistant molecular marker, K13 have been identified and it was used as a tool in this study.

Clinical Trial Description

n/a

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Day-3 Positive of Parasitaemia
• Parasitemia
• Prevalence of Drug Resistance Gene Mutation

• NCT number: NCT02198573
• Study type: Observational
• Source: Department of Medical Research, Lower Myanmar
• Status: Completed
• Phase: N/A
• Start date: July 2013
• Completion date: June 2014